[New solution for the resuspension and preservation of erythrocyte masses].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 6217461)

Published in Probl Gematol Pereliv Krovi on October 01, 1982

Authors

V A Agranenko, N A Markova, I A Suvorova, N N Firsov, E V Viazova

Articles by these authors

Aggregation and disaggregation of erythrocytes in whole blood: study by backscattering technique. J Biomed Opt (1999) 0.92

Alternative reprogramming of M1/M2 phenotype of mouse peritoneal macrophages in vitro with interferon-γ and interleukin-4. Bull Exp Biol Med (2012) 0.80

[Post-stroke vascular dementia: risk factors and clinical neuro-imaging features]. Adv Gerontol (2010) 0.76

[The mechanism of the prevention by ethomersol of disorders in erythrocyte deformability in cerebral ischemia and recirculation]. Eksp Klin Farmakol (1993) 0.76

[Blood transfusion complications in the obstetric and gynecological practice, their prevention and treatment]. Akush Ginekol (Mosk) (1969) 0.75

[Comparative evaluation of methods of exchange blood transfusion]. Probl Gematol Pereliv Krovi (1969) 0.75

[The therapeutic efficacy of transfusions of erythrocyte mass in anemia in patients with internal diseases]. Gematol Transfuziol (1989) 0.75

[Preserved blood components in surgery]. Vestn Khir Im I I Grek (1982) 0.75

[Acid-base equilibrium in arterial and venous blood in blood transfusion shock]. Biull Eksp Biol Med (1968) 0.75

[Citroglucophosphate, an effective preservative solution for blood]. Sov Med (1979) 0.75

[Evaluation of the vital capacity of erythrocytes of cadaver blood using the isotope chromium Cr 51]. Probl Gematol Pereliv Krovi (1970) 0.75

[HB-antigen content in cryopreserved erythrocytes]. Probl Gematol Pereliv Krovi (1978) 0.75

[Therapeutic efficacy of defrosted erythrocyte pack in complex treatment of patients with traumatic shock and acute blood loss]. Probl Gematol Pereliv Krovi (1977) 0.75

[Clinical use of frozen blood]. Sov Med (1977) 0.75

[New method of preparing functionally active thrombocyte concentrates from preserved blood after 1-5 days of storage]. Gematol Transfuziol (1983) 0.75

Preparing platelet concentrates from banked blood stored for 1-5 days by using tetracycline antibiotics. Folia Haematol Int Mag Klin Morphol Blutforsch (1983) 0.75

[Study of morphology and some biochemical indices of preserved blood by different prescriptions of donor blood under condition of its circulation in the apparatus for artificial circulation]. Probl Gematol Pereliv Krovi (1968) 0.75

[Peculiarities of the selection of blood and the conduct of compatibility tests in patients with transfustion complications]. Probl Gematol Pereliv Krovi (1967) 0.75

[Period of preservation of the functional properties of granulocytes isolated by blood cell separation]. Probl Gematol Pereliv Krovi (1982) 0.75

[Hemorrhagic complications in acute renal insufficiency and the state of the blood coagulation system]. Urol Nefrol (Mosk) (1970) 0.75

[Transfusion of whole fibrinolysed blood and its thawn erythrocytes in surgery of the main blood vessels]. Probl Gematol Pereliv Krovi (1978) 0.75

[Restoration of the viability of preserved blood after long-term storage]. Gematol Transfuziol (1983) 0.75

[Clinical evaluation of the effectiveness of transfusions of erythrocytic mass]. Sov Med (1975) 0.75

[Effect of pH on the regulatory characteristics of energy metabolism in human erythrocytes]. Biokhimiia (1986) 0.75

[Acid-base equilibrium of whole blood and erythrocytes in healthy subjects]. Lab Delo (1968) 0.75

[A new solution for blood preservation containing adenine, nicotinamide and phosphates]. Gematol Transfuziol (1985) 0.75

[Cryopreservation of erythrocytes, their clinical use and prospects for this method]. Sov Med (1978) 0.75

[Clinical use of cadaver blood preserved with sucrose solution and levomycetin]. Voen Med Zh (1971) 0.75

[Principles of component hemotherapy]. Probl Gematol Pereliv Krovi (1978) 0.75

[A case of uremic poisoning in acute renal insufficiency accompanied by moderate azotemia]. Klin Med (Mosk) (1967) 0.75

[Autologous blood transfusion in surgery (review of the literature)]. Probl Gematol Pereliv Krovi (1977) 0.75

[Preservation of blood intended for filling of the apparatus for extracorporeal circulation (AEC) prepared on glucose-phosphate preservative with citric acid (formula TsOLIPK 12 A)]. Probl Gematol Pereliv Krovi (1973) 0.75

[Functional properties of thrombocytes preserved with solutions of TsOLIPK 76 and citroglucophosphate and stored at temperatures of 4 and 22 degrees C]. Probl Gematol Pereliv Krovi (1979) 0.75

[Acid-base balance in erythrocytes of the venous and arterial blood in hemotransfusion shock]. Patol Fiziol Eksp Ter (1970) 0.75

[Study of the properties of erythrocytes frozen with the high concentration of glycerin at moderately low temperatures and their clinical application]. Probl Gematol Pereliv Krovi (1975) 0.75

[Method of assessing the functional value of preserved thrombocytes based on the induced peroxide oxidation of thrombocyte membrane lipids]. Probl Gematol Pereliv Krovi (1980) 0.75

[Biological properties of cryopreserved leukocytes and their clinical application]. Probl Gematol Pereliv Krovi (1982) 0.75

[A filtration study of erythrocyte deformability]. Gematol Transfuziol (1993) 0.75

[Washing off the glycerin from cryopreserved erythrocytes by using reverse cytoagglomeration]. Probl Gematol Pereliv Krovi (1979) 0.75

[Comparative characteristics of an erythrocyte suspension with different plasma-substitute solutions]. Probl Gematol Pereliv Krovi (1980) 0.75

[Biochemical modification of an erythrocyte mass having lost its effectiveness after an extremely long storage time]. Gematol Transfuziol (1988) 0.75

[Oxygen regimen characteristics of an isolated heart during its perfusion with human erythrocyte suspension, prepared in glugicir solution, after short and long storage periods]. Gematol Transfuziol (1991) 0.75

[Effect of cryopreservation on lowering the risk of posttransfusional complications related to the transfer of viral hepatitis and bacterial blood contamination]. Probl Gematol Pereliv Krovi (1977) 0.75

[Rheopolyglucin in the prevention of postperfusion complications associated with use of massive doses of donor blood during open heart surgery]. Probl Gematol Pereliv Krovi (1969) 0.75

[Transfusion of erythrocytic mass after various lengths of preservation in anemia]. Gematol Transfuziol (1987) 0.75

[Cryopreserved thrombocytes and their clinical efficacy]. Gematol Transfuziol (1987) 0.75

[Problems of transfusiology in cardio-vascular surgery (Soviet-American scientific cooperation)]. Probl Gematol Pereliv Krovi (1975) 0.75

[Use of a cryopreserved autoerythrocytic mass in the surgical treatment of pulmonary tuberculosis]. Probl Tuberk (1976) 0.75

[Functional properties of granulocytes obtained by automatic cytopheresis]. Probl Gematol Pereliv Krovi (1981) 0.75

[Cryopreservation of erythrocytic mass restored after long-term storage]. Probl Gematol Pereliv Krovi (1977) 0.75

[Thrombin-induced prostaglandin synthesis by thrombocytes under different preservation conditions]. Probl Gematol Pereliv Krovi (1982) 0.75

[Methods of isolating thrombocytes and leukocytes from the leuko-thrombocytic layer of blood preserved in plastic bags]. Gematol Transfuziol (1985) 0.75

[Morphofunctional quality of blood and erythrocyte concentrate preserved in polymeric containers and small glass bottles]. Gematol Transfuziol (1987) 0.75

[Rheological characteristics of preserved blood and of an erythrocyte mass]. Probl Gematol Pereliv Krovi (1981) 0.75

[Morphofunctional characteristics of erythrocyte masses resuspended in a new preserving solution]. Gematol Transfuziol (1985) 0.75

[Analysis of the sedimentation separation of leukocytes and erythrocytes in preserved blood stored in small glass bottles and plastic containers]. Gematol Transfuziol (1986) 0.75

[Refractory effect and alloimmunization after transfusion of thrombocytes]. Gematol Transfuziol (1992) 0.75

[Effect of room temperature on the storage of preserved blood and red cell mass]. Gematol Transfuziol (1988) 0.75

[Comparative evaluation of clinical effect of cadaveric blood, prepared with different preservatives]. Probl Gematol Pereliv Krovi (1973) 0.75

ADP-induced refractoriness of platelets preserved in different temperature conditions. Folia Haematol Int Mag Klin Morphol Blutforsch (1985) 0.75

[Blood service and the science of transfusions on the 60th anniversary of the formation of the USSR]. Probl Gematol Pereliv Krovi (1982) 0.75

[Comparative characteristics of packed red cells and whole blood prepared with different blood preservatives]. Probl Gematol Pereliv Krovi (1976) 0.75

[Rheological properties of preserved blood stored in polymer containers and glass vials]. Gematol Transfuziol (1989) 0.75

[Transmission of viral infections during transfusion of blood and its components]. Gematol Transfuziol (1991) 0.75

[Preservation and cryopreservation of blood cells--achievements and prospects]. Gematol Transfuziol (1987) 0.75

[Therapeutic effectiveness of preserved thrombocytic concentrates]. Klin Med (Mosk) (1989) 0.75

[Platelet transfusions in systemic blood diseases]. Gematol Transfuziol (1994) 0.75

[Complications of massive blood transfusion during surgery with artificial blood circulation (homologous blood syndrome)]. Khirurgiia (Mosk) (1968) 0.75

[Erythropoietins and ceruloplasmin in acute renal insufficiency]. Ter Arkh (1968) 0.75

[Cryopreservation of granulocytes using "Leukocryodmac" solution]. Gematol Transfuziol (1986) 0.75

[Isolation of thrombocyte concentrates from the leuko-thrombocytic buffy coats of donor blood and their preservation]. Gematol Transfuziol (1991) 0.75

[Deglycerinization of thawed erythrocytes on the PK-05 apparatus]. Gematol Transfuziol (1983) 0.75

[Choice of an effective resuspending solution for thawed washed erythrocytes from cadaver blood]. Voen Med Zh (1976) 0.75

[Functional viability of the thrombocytes in preserved blood stored 1-7 days]. Probl Gematol Pereliv Krovi (1981) 0.75

[Initial experience with the clinical use of an erythrocyte mass resuspended and preserved in an Eritronaf solution]. Gematol Transfuziol (1988) 0.75

Transformations of glycolysis control characteristics in human erythrocytes during blood storage. Folia Haematol Int Mag Klin Morphol Blutforsch (1984) 0.75

[The oxygen system of an isolated heart during its perfusion with a suspension of human erythrocytes after different periods of their preservation in a solution containing adenine]. Gematol Transfuziol (1991) 0.75

[Preservation of platelet concentrates isolated from platelet-enriched donor plasma]. Gematol Transfuziol (1992) 0.75

[Efficacy of transfusions of defrosted washed erythrocytes in complex treatment of anemia in patients with chronich renal insufficiency]. Urol Nefrol (Mosk) (1977) 0.75

[Updated approaches to erythrocyte and platelet transfusions in children]. Gematol Transfuziol (1996) 0.75

[Preservation of an erythrocyte concentrate with leukocytes and thrombocytes removed (isolation methods and the transfusion advantages)]. Probl Gematol Pereliv Krovi (1980) 0.75

[Preservation of blood and its use]. Arch Pathol Lab Med (1975) 0.75

[Disturbance of the acid-base equilibrium in acute renal insufficiency]. Klin Med (Mosk) (1968) 0.75

[Method of restoration (rejuvenation) of preserved erythrocytes stored over the maximum period of time]. Sov Med (1976) 0.75

Combined action of nicotinamide and adenine in preservation of packed red cells. Folia Haematol Int Mag Klin Morphol Blutforsch (1987) 0.75

[Effectiveness of thrombocyte concentrate transfusions during operations with an increased risk for hemorrhagic complications]. Gematol Transfuziol (1988) 0.75

[Prevention of renal insufficiency following transfusion of incompatible blood]. Probl Gematol Pereliv Krovi (1967) 0.75

[Work of the army mobile blood transfusion station during the Great Patriotic War]. Probl Gematol Pereliv Krovi (1975) 0.75

[Changes in iron ion-induced lipid peroxidation in blood platelet membranes after preservation and cryopreservation]. Probl Gematol Pereliv Krovi (1982) 0.75

[Blast-cell bank designated for carrying out immunological studies and immunotherapy of leukemia]. Probl Gematol Pereliv Krovi (1977) 0.75

[Evaluation of the degree of delgycerinization of thawed, washed erythrocytes using a cryoscopic method]. Probl Gematol Pereliv Krovi (1978) 0.75

[The oxygen supply of the isolated rat heart during perfusion with a suspension of human erythrocytes prepared on the blood preservative citroglucophosphate]. Gematol Transfuziol (1989) 0.75

[Comparative characteristics of the effectiveness of oxygen delivery to the tissues by human erythrocytes preserved with glugicir and citroglucophosphate]. Gematol Transfuziol (1991) 0.75

[Erythrocyte preservation in liquid nitrogen vapors]. Probl Gematol Pereliv Krovi (1977) 0.75

[Blood banks during World War II (on the 40th anniversary of the Victory)]. Gematol Transfuziol (1985) 0.75

[Effect of rheopolyglucin on the aggregation function of erythrocytes stored for different times]. Farmakol Toksikol (1979) 0.75

[Changes in the regulatory characteristics of glycolysis in erythrocytes during storage of donor blood]. Vopr Med Khim (1984) 0.75

[ATP and 2,3-DPG content of blood prepared on TSOLIPK no. 12-A and TSOLIK no. 7b preservatives]. Probl Gematol Pereliv Krovi (1974) 0.75

[Change of the oxygen-transport function of the erythrocytes during storage of blood preserved by different methods]. Probl Gematol Pereliv Krovi (1977) 0.75